- Home
- RSSS vs EPIX Comparison
RSSS vs EPIX Comparison
Compare RSSS & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- EPIX
- Stock Information
- Founded
- RSSS 2006
- EPIX 2009
- Country
- RSSS United States
- EPIX Canada
- Employees
- RSSS N/A
- EPIX N/A
- Industry
- RSSS Business Services
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- RSSS Consumer Discretionary
- EPIX Health Care
- Exchange
- RSSS Nasdaq
- EPIX Nasdaq
- Market Cap
- RSSS 90.6M
- EPIX 75.9M
- IPO Year
- RSSS N/A
- EPIX N/A
- Fundamental
- Price
- RSSS $2.95
- EPIX $1.72
- Analyst Decision
- RSSS
- EPIX Hold
- Analyst Count
- RSSS 0
- EPIX 3
- Target Price
- RSSS N/A
- EPIX $2.00
- AVG Volume (30 Days)
- RSSS 44.9K
- EPIX 53.1K
- Earning Date
- RSSS 05-08-2025
- EPIX 08-04-2025
- Dividend Yield
- RSSS N/A
- EPIX N/A
- EPS Growth
- RSSS N/A
- EPIX N/A
- EPS
- RSSS N/A
- EPIX N/A
- Revenue
- RSSS $48,753,578.00
- EPIX N/A
- Revenue This Year
- RSSS $12.42
- EPIX N/A
- Revenue Next Year
- RSSS $7.47
- EPIX N/A
- P/E Ratio
- RSSS N/A
- EPIX N/A
- Revenue Growth
- RSSS 14.85
- EPIX N/A
- 52 Week Low
- RSSS $2.32
- EPIX $1.40
- 52 Week High
- RSSS $4.24
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- RSSS 54.66
- EPIX 51.31
- Support Level
- RSSS $2.94
- EPIX $1.68
- Resistance Level
- RSSS $3.10
- EPIX $1.75
- Average True Range (ATR)
- RSSS 0.09
- EPIX 0.04
- MACD
- RSSS 0.02
- EPIX 0.00
- Stochastic Oscillator
- RSSS 62.45
- EPIX 62.50
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.